Chronic Disease Volume Is Straining Endocrinology Practices
Endocrinology practices manage some of the highest-volume chronic disease populations in specialty medicine. Diabetes, thyroid disorders, obesity, adrenal conditions, and osteoporosis each require ongoing monitoring, lab work review, medication management, and coordination with ancillary providers including diabetes educators, dietitians, and pharmacists. The administrative workload generated by this level of longitudinal care is substantial — and growing.
The Endocrine Society's 2025 Practice Management Survey found that endocrinology practices saw a 19% increase in patient visit volume between 2022 and 2025, driven primarily by the expanding type 2 diabetes and pre-diabetes population. Staff-to-physician ratios did not keep pace. The same survey found that 64% of endocrinology practice managers reported that lab result follow-up and prior authorization management were the two functions most frequently delayed due to insufficient administrative staffing.
Virtual assistants (VAs) with endocrinology-specific training are being used to absorb these chronic disease management coordination tasks, allowing clinical staff to focus on patient care rather than administrative follow-through.
What an Endocrinology VA Manages
Lab result follow-up is one of the highest-frequency workflows in endocrinology. Diabetic patients require quarterly HbA1c testing; thyroid patients need TSH monitoring; adrenal patients may require cortisol, aldosterone, and other panels on rotating schedules. When results return, someone must review them for out-of-range flags, communicate results to patients per practice protocol, and schedule follow-up appointments or medication adjustments. VAs manage this follow-up workflow — contacting patients with normal results per approved templates, flagging abnormal values for clinical review, and scheduling follow-up visits when the provider determines action is needed.
CGM supply coordination is an increasingly significant workflow as continuous glucose monitoring becomes standard of care for type 1 and type 2 diabetes patients on insulin. CGM devices (Dexcom, Abbott FreeStyle Libre, Medtronic) require periodic sensor and transmitter replenishment through DME suppliers, and the authorization and reorder process is paper-intensive. VAs track CGM supply cycles, initiate reorders, coordinate with DME vendors, manage prior authorization renewals, and follow up with patients who have not received or collected their supplies.
Diabetes educator referrals require administrative coordination that often falls through the cracks in busy endocrinology practices. When a provider determines that a patient needs structured diabetes self-management education (DSME), the VA processes the referral to the in-house or affiliated diabetes education program, confirms the patient has scheduled, and tracks program completion — closing the referral loop and ensuring documentation supports payer billing requirements for DSME services.
Prior authorization follow-up in endocrinology is particularly demanding for insulin analogs, GLP-1 agonists (semaglutide, tirzepatide), SGLT-2 inhibitors, and CGM devices — all of which face significant payer scrutiny. VAs manage the prior auth lifecycle: initiating submissions, tracking approval windows, compiling supporting documentation for step therapy exceptions, and alerting providers when reauthorization deadlines approach.
The Outcomes Data Supporting VA Deployment
A 2024 American Diabetes Association (ADA) practice efficiency study found that endocrinology practices with structured lab result follow-up protocols — regardless of whether those protocols were managed in-house or by remote staff — had 22% lower rates of patients with HbA1c above 9% in the subsequent quarter. The study attributed improved outcomes to faster identification of patients with suboptimal control and timelier intervention scheduling.
On the CGM front, a 2025 analysis by the Connected Diabetes Cooperative found that practices with dedicated CGM supply coordination support had 34% higher rates of continued CGM use at 12 months versus practices where supply reordering was entirely patient-initiated. Supply continuity directly correlates with glycemic control improvements.
Technology Integration
Endocrinology VAs work within EHR platforms including Epic, Athenahealth, eClinicalWorks, and Greenway Health. CGM data interfaces with manufacturer platforms (Dexcom Clarity, LibreView) that VAs can access for supply tracking and compliance documentation. Prior authorization workflows run through payer portals and clearinghouses including CoverMyMeds and Availity.
Conclusion
For endocrinology practices managing large chronic disease populations, virtual assistants address the specific administrative workflows — lab follow-up, CGM supply coordination, diabetes education referrals, prior auth — that require consistent execution but don't require a clinical license. The result is better care continuity, fewer administrative gaps, and a lower burden on in-office clinical staff.
Endocrinology practices ready to explore VA support can learn more at Stealth Agents.
Sources
- Endocrine Society Practice Management Survey, 2025
- American Diabetes Association Practice Efficiency Study, 2024
- Connected Diabetes Cooperative CGM Adherence Analysis, 2025